P
CME icon

&Partners’s CME Group CME Stock Holding History

&Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.7M Buy
100,458
+9,124
+10% +$2.71M 0.15% 127
2025
Q4 		$24.9M Buy
91,334
+26,135
+40% +$7.1M 0.13% 148
2025
Q3 		$17.7M Buy
65,199
+8,942
+16% +$2.43M 0.11% 169
2025
Q2 		$15.5M Buy
56,257
+12,089
+27% +$3.29M 0.12% 170
2025
Q1 		$11.6M Sell
44,168
-837
-2% -$206K 0.12% 161
2024
Q4 		$10.5M Buy
45,005
+14,648
+48% +$3.37M 0.13% 164
2024
Q3 		$6.69M Buy
30,357
+28,360
+1,420% +$5.87M 0.13% 163
2024
Q2 		$393K Buy
+1,997
New +$413K 0.02% 624

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

&Partners's CME Position: Q1 2026 in Review

&Partners increased its CME Group (CME) stake by 10% in Q1 2026, buying an estimated $2.71M and bringing the position to 100,458 shares worth $29.7M. The position accounts for 0.15% of the portfolio, ranked #127.

&Partners first reported a position in CME in Q2 2024 and has held it in 8 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • &Partners held 100,458 shares of CME Group worth $29.7M as of Q1 2026.
  • &Partners bought 9,124 CME Group shares in Q1 2026, an estimated $2.71M.
  • CME Group made up 0.15% of &Partners's portfolio in Q1 2026, its #127 holding.
  • &Partners first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.